Fund Holdings — Deep Track Capital, LP

Total Portfolio Value:
$3.35B
Total Bought:
$661.67M
Total Sold:
$440.20M
Net Transaction:
+$221.47M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Amgen Inc.(AMGN)550,000575,000+25,000$156.38M$179.66M5.37%+$23.28M
argenx SEADR(ARGX)300,000400,000+100,000$118.12M$172.02M5.14%+$53.90M
Axsome Therapeutics, Inc.(AXSM)1,304,7211,852,784+548,063$104.12M$149.15M4.45%+$45.03M
Dyne Therapeutics, Inc.(DYN)4,555,3834,000,000-555,383$129.33M$141.16M4.22%+$11.83M
Springworks Therapeutics Inc3,479,8533,700,000+220,147$171.28M$139.38M4.16%-$31.90M
Insmed Incorporated(INSM)4,783,6792,000,000-2,783,679$129.78M$134.00M4.00%+$4.22M
Guardant Health, Inc.(GH)6,000,0004,500,000-1,500,000$123.78M$129.96M3.88%+$6.18M
Dynavax Technologies Corp9,141,66010,900,000+1,758,340$113.45M$122.41M3.66%+$8.96M
Alnylam Pharmaceuticals, Inc.(ALNY)832,310500,000-332,310$124.39M$121.50M3.63%-$2.89M
Intellia Therapeutics, Inc.(NTLA)4,210,7844,800,000+589,216$115.84M$107.42M3.21%-$8.41M
Intra-Cellular Therapies Inc1,500,0001,537,922+37,922$103.80M$105.33M3.15%+$1.53M
Apellis Pharmaceuticals Inc
COM
1,000,0002,500,000+1,500,000$58.78M$95.90M2.86%+$37.12M
Ionis Pharmaceuticals, Inc.(IONS)1,373,4752,000,000+626,525$59.54M$95.32M2.85%+$35.78M
Ocular Therapeutix, Inc.(OCUL)12,721,46012,721,4600$115.77M$87.01M2.60%-$28.75M
4d Molecular Therapeutics In3,034,4534,061,401+1,026,948$96.68M$85.25M2.55%-$11.43M
Alkermes plcSHS(ALKS)3,500,0003,500,0000$94.75M$84.35M2.52%-$10.39M
Nurix Therapeutics, Inc.(NRIX)2,997,8303,991,500+993,670$44.07M$83.30M2.49%+$39.23M
Immunovant, Inc.(IMVT)493,3522,883,736+2,390,384$15.94M$76.13M2.27%+$60.19M
Bicycle Therapeutics PlcADS3,490,5063,490,5060$86.91M$70.65M2.11%-$16.27M
Pliant Therapeutics, Inc.(PLRX)5,750,0005,972,257+222,257$85.67M$64.20M1.92%-$21.47M
Travere Therapeutics, Inc.(TVTX)7,370,0007,370,0000$56.82M$60.58M1.81%+$3.76M
Verona Pharma PlcADS3,187,4154,000,000+812,585$51.29M$57.84M1.73%+$6.55M
ABIVAX Société AnonymeADS(ABVX)4,297,4384,179,763-117,675$61.45M$55.26M1.65%-$6.20M
Geron Corporation(GERN)30,505,92913,000,000-17,505,929$100.67M$55.12M1.65%-$45.55M
Autolus Therapeutics plcADS(AUTL)15,272,17215,272,1720$97.44M$53.15M1.59%-$44.29M
TG Therapeutics, Inc.(TGTX)02,870,131+2,870,131$0$51.06M1.52%+$51.06M
Viridian Therapeutics, Inc.(VRDN)3,456,0533,923,849+467,796$60.52M$51.05M1.52%-$9.47M
Kymera Therapeutics, Inc.(KYMR)1,262,2461,500,000+237,754$50.74M$44.77M1.34%-$5.97M
Mind Medicine Mindmed Inc6,666,6676,103,817-562,850$62.67M$44.01M1.31%-$18.66M
Olema Pharmaceuticals, Inc.(OLMA)3,225,4194,000,000+774,581$36.51M$43.28M1.29%+$6.77M
Terns Pharmaceuticals Inc6,100,0006,100,0000$40.02M$41.54M1.24%+$1.52M
Spyre Therapeutics, Inc.(SYRE)1,213,4201,756,667+543,247$46.03M$41.30M1.23%-$4.73M
Apogee Therapeutics Inc2,323,4561,000,000-1,323,456$154.39M$39.35M1.18%-$115.04M
Structure Therapeutics IncADS40,137950,000+909,863$1.72M$37.31M1.11%+$35.59M
ANI Pharmaceuticals, Inc.(ANIP)822,001466,089-355,912$56.82M$29.68M0.89%-$27.14M
Editas Medicine, Inc.(EDIT)5,527,2906,000,000+472,710$41.01M$28.02M0.84%-$12.99M
Climb Bio, Inc.(CLYM)03,904,785+3,904,785$0$27.76M0.83%+$27.76M
Hillevax Inc2,572,4601,832,652-739,808$42.78M$26.50M0.79%-$16.28M
Korro Bio, Inc.(KRRO)0770,645+770,645$0$26.10M0.78%+$26.10M
Silence Therapeutics plcADS(SLN)1,643,8811,359,745-284,136$35.51M$25.84M0.77%-$9.67M
Nektar Therapeutics(NKTR)18,400,00017,875,498-524,502$17.19M$22.17M0.66%+$4.98M
Engene Holdings Inc
COM
2,250,0002,250,0000$38.14M$21.22M0.63%-$16.92M
Alector Inc3,769,3864,631,998+862,612$22.69M$21.03M0.63%-$1.66M
89bio Inc02,294,011+2,294,011$0$18.38M0.55%+$18.38M
Fate Therapeutics, Inc.(FATE)5,572,6075,572,6070$40.90M$18.28M0.55%-$22.62M
Inovio Pharmaceuticals, Inc.(INO)02,066,720+2,066,720$0$16.70M0.50%+$16.70M
Praxis Precision Medicines, Inc.(PRAX)0389,546+389,546$0$16.11M0.48%+$16.11M
Cybin D/B/A Helus Pharma(HELP)58,139,53558,139,5350$24.04M$15.76M0.47%-$8.28M
Context Therapeutics Inc.(CNTX)07,419,355+7,419,355$0$14.88M0.44%+$14.88M
Pyxis Oncology, Inc.(PYXS)4,184,1004,184,1000$17.82M$13.85M0.41%-$3.97M
Invivyd, Inc.(IVVD)10,953,93710,953,9370$48.64M$12.05M0.36%-$36.59M
Zura Bio LimitedCL A(ZURA)2,523,0003,283,783+760,783$6.48M$11.49M0.34%+$5.01M
Kura Oncology, Inc.(KURA)0384,756+384,756$0$7.92M0.24%+$7.92M
Cytokinetics, Incorporated(CYTK)0132,495+132,495$0$7.18M0.21%+$7.18M
Regulus Therapeutics Inc3,266,5663,262,564-4,002$9.41M$5.82M0.17%-$3.58M
Alto Neuroscience, Inc.(ANRO)600,000511,686-88,314$9.21M$5.47M0.16%-$3.74M
Agenus Inc.(AGEN)0313,359+313,359$0$5.25M0.16%+$5.25M
Allakos Inc5,000,0005,000,0000$6.30M$5.00M0.15%-$1.30M
Syros Pharmaceuticals Inc828,485828,4850$4.43M$4.27M0.13%-$157.4K
Relmada Therapeutics, Inc.(RLMD)1,240,0341,234,773-5,261$5.77M$3.70M0.11%-$2.06M
Edgewise Therapeutics, Inc.(EWTX)0186,386+186,386$0$3.36M0.10%+$3.36M
Scholar Rock Holding Corporation(SRRK)680,000372,559-307,441$12.08M$3.10M0.09%-$8.97M
Repare Therapeutics Inc2,684,344904,261-1,780,083$12.64M$2.98M0.09%-$9.66M
Cogent Biosciences, Inc.(COGT)316,000308,235-7,765$2.12M$2.60M0.08%+$474.9K
Vigil Neuroscience Inc1,594,931597,215-997,716$5.44M$2.39M0.07%-$3.05M
Aligos Therapeutics Inc6,102,7706,102,7700$5.98M$2.14M0.06%-$3.84M
Metagenomi Therapeutics, Inc.(MGX)466,232466,2320$4.92M$1.90M0.06%-$3.02M
Agenus Inc.(AGEN)31,697,5390-31,697,539$18.38M$0—-$18.38M
Anaptysbio Inc529,4520-529,452$11.92M$0—-$11.92M
Mersana Therapeutics Inc579,6740-579,674$2.60M$0—-$2.60M
Neumora Therapeutics, Inc.(NMRA)1,000,0000-1,000,000$13.75M$0—-$13.75M
Nuvalent Inc274,5120-274,512$20.61M$0—-$20.61M
Pacific Biosciences of California, Inc.(PACB)7,000,0000-7,000,000$26.25M$0—-$26.25M
Prime Medicine, Inc.(PRME)303,7160-303,716$2.13M$0—-$2.13M
Tourmaline Bio Inc1,595,4000-1,595,400$36.53M$0—-$36.53M
Ultragenyx Pharmaceutical Inc.(RARE)167,7840-167,784$7.83M$0—-$7.83M
Page 1 of 1
Deep Track Capital, LP — 13F Holdings — Q2 2024 | TickerTrail